Home > News > Spire to develop technology for orthopedic prostheses
August 12th, 2003
Spire to develop technology for orthopedic prostheses
Spire Corp. has received a two-year, $750,000 SBIR Phase II grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases to develop nanotechnology coatings. Under the grant, Spire will develop hard, extremely adherent nanocrystalline coatings for orthopedic implants. The coatings contain metallic bonding and have a chemical composition very similar to the substrate. Feasibility of the technology was demonstrated during a Phase I grant.
Harris & Harris Group Reports Financial Statements as of December 31, 2014 and Posts Annual Letter to Shareholders on Website March 17th, 2015
Arrowhead to Present at 2015 Barclays Global Healthcare Conference March 4th, 2015
Arrowhead to Present at 2015 RBC Capital Markets' Global Healthcare Conference February 17th, 2015
Iran 1st among Islamic Nations in Scientific Production, Nanotechnology February 16th, 2015